Recent data have identified IL-9 as a key cytokine in determining susceptib
ility to asthma. These data are supported by the finding that allergen-expo
sed IL-9-transgenic mice exhibit many features that are characteristic of h
uman asthma (airway eosinophilia, elevated serum IgE and bronchial hyperres
ponsiveness) as compared to the background strain. A striking feature of th
ese animals is a robust peribronchial and perivascular eosinophilia after a
llergen challenge, suggesting that IL-9 is a potent factor in regulating th
is process. In an attempt to gain insights into the molecular mechanism gov
erning IL-9 modulation of lung eosinophilia, we investigated the ability of
this cytokine to induce the expression of CC-type chemokines in the lung b
ecause of their effect on stimulating eosinophil chemotaxis. Here we show t
hat IL-9-transgenic mice in contrast to their congenic controls exhibit bas
eline lung eosinophilia that is associated with the up-regulation of CC-che
mokine expression in the airway. This effect appears to be through a direct
action of IL-9 because the addition of recombinant IL-9 to primary epithel
ial cultures and cell lines induced the expression of these chemokines in v
itro. These data support a mechanism for IL-9 in regulating the expression
of eosinophil chemotactic factors in lung epithelial cells.